Go Pro
NASDAQ:ASPI

ASP Isotopes Q2 2026 Earnings Report

ASP Isotopes logo
$2.92 -0.03 (-1.02%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$2.94 +0.02 (+0.68%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ASP Isotopes EPS Results

Actual EPS
-$0.28
Consensus EPS
-$0.17
Beat/Miss
Missed by -$0.11
One Year Ago EPS
N/A

ASP Isotopes Revenue Results

Actual Revenue
$5.12 million
Expected Revenue
$4.47 million
Beat/Miss
Beat by +$657.00 thousand
YoY Revenue Growth
N/A

ASP Isotopes Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Friday, August 14, 2026
Conference Call Time
7:00AM ET

Upcoming Earnings

ASP Isotopes' Q3 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules

Earnings Documents

ASP Isotopes Earnings Headlines

ASP Isotopes Inc (ASPI)
ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
ASP Isotopes Inc. (ASPI) Analyst/Investor Day - Slideshow
See More ASP Isotopes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ASP Isotopes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ASP Isotopes and other key companies, straight to your email.

About ASP Isotopes

ASP Isotopes (NASDAQ:ASPI) (NASDAQ: ASPI) is a development-stage company focused on isotope enrichment and related technologies. The company is developing an isotope-separation platform known as the Aerodynamic Separation Process, which is intended to enrich selected chemical elements and isotopes for use in several specialized markets.

ASP Isotopes has identified applications in the nuclear energy, medical, semiconductor, and quantum-computing industries. Its development programs have included uranium enrichment as well as the production of specialty isotopes such as carbon-14, molybdenum-100, and silicon-28. These materials may be used in nuclear fuel, medical diagnostics and treatment, advanced semiconductor manufacturing, and other research and industrial applications.

The company is headquartered in the United States and has pursued isotope-enrichment activities and development partnerships internationally, including work connected with South Africa. ASP Isotopes remains focused on advancing its technology, developing production capabilities, and commercializing enriched isotope products across its targeted markets.

View ASP Isotopes Profile